These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10516628

  • 1. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.
    Miyazaki M, Sakonjo H, Takai S.
    Br J Pharmacol; 1999 Oct; 128(3):523-9. PubMed ID: 10516628
    [Abstract] [Full Text] [Related]

  • 2. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.
    Song K, Shiota N, Takai S, Takashima H, Iwasaki H, Kim S, Miyazaki M.
    Atherosclerosis; 1998 May; 138(1):171-82. PubMed ID: 9678783
    [Abstract] [Full Text] [Related]

  • 3. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet.
    Miyazaki M, Takai S.
    Hypertens Res; 1999 Mar; 22(1):49-54. PubMed ID: 10221351
    [Abstract] [Full Text] [Related]

  • 4. Anti-atherosclerotic efficacy of olmesartan.
    Miyazaki M, Takai S.
    J Hum Hypertens; 2002 May; 16 Suppl 2():S7-12. PubMed ID: 11967727
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin converting enzyme inhibitors and atherosclerosis.
    Andersson RG, Jacobsson L, Persson K.
    J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
    Takai S, Jin D, Sakaguchi M, Muramatsu M, Ishii K, Kirimura K, Sakonjo H, Miyazaki M.
    Hypertens Res; 2004 Jul; 27(7):517-22. PubMed ID: 15302989
    [Abstract] [Full Text] [Related]

  • 9. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril.
    Hoshida S, Nishida M, Yamashita N, Igarashi J, Aoki K, Hori M, Kuzuya T, Tada M.
    Atherosclerosis; 1997 Apr; 130(1-2):53-9. PubMed ID: 9126648
    [Abstract] [Full Text] [Related]

  • 10. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
    Sugano M, Makino N, Yanaga T.
    Atherosclerosis; 1996 Nov 15; 127(1):123-9. PubMed ID: 9006812
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit.
    Chobanian AV, Hope S, Brecher P.
    Hypertension; 1995 Jun 15; 25(6):1306-10. PubMed ID: 7768578
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S, Nakano K, Hirouchi Y, Kohjimoto Y, Kitajima S, Usui M, Inoue S, Egashira K.
    Arterioscler Thromb Vasc Biol; 2004 Aug 15; 24(8):1522-8. PubMed ID: 15178560
    [Abstract] [Full Text] [Related]

  • 13. An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit.
    Fennessy PA, Campbell JH, Campbell GR.
    Clin Sci (Lond); 1994 Dec 15; 87(6):685-91. PubMed ID: 7874860
    [Abstract] [Full Text] [Related]

  • 14. The regressive effect of an angiotensin II receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet.
    Takai S, Jin D, Sakaguchi M, Muramatsu M, Miyazaki M.
    J Hypertens; 2005 Oct 15; 23(10):1879-86. PubMed ID: 16148612
    [Abstract] [Full Text] [Related]

  • 15. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
    Secchi J, Lecaque D, Dunn FW, Jouquey S, Auberval UD, Benzoni F, Sirugue O, Hamon G.
    J Cardiovasc Pharmacol; 1994 Oct 15; 23 Suppl 4():S30-7. PubMed ID: 7527099
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
    Hope S, Brecher P, Chobanian AV.
    Am J Hypertens; 1999 Jan 15; 12(1 Pt 1):28-34. PubMed ID: 10075381
    [Abstract] [Full Text] [Related]

  • 17. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
    Li J, Hirose N, Kawamura M, Arai Y.
    Atherosclerosis; 1999 Apr 15; 143(2):315-26. PubMed ID: 10217360
    [Abstract] [Full Text] [Related]

  • 18. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture.
    Fennessy PA, Campbell JH, Campbell GR.
    Atherosclerosis; 1994 Mar 15; 106(1):29-41. PubMed ID: 8018105
    [Abstract] [Full Text] [Related]

  • 19. Phenolic compounds from sandpaper (ficus exasperata) leaf inhibits angiotensin 1 converting enzyme in high cholesterol diet fed rats.
    Oboh G, Akinyemi AJ, Osanyinlusi FR, Ademiluyi AO, Boligon AA, Athayde ML.
    J Ethnopharmacol; 2014 Nov 18; 157():119-25. PubMed ID: 25267581
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits.
    Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH.
    J Clin Invest; 1993 Apr 18; 91(4):1453-8. PubMed ID: 8473494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.